Skip to content
MarketScale
‹ Back to IndustriesSciences

For Wider Adoption of Small Modular Nuclear Reactors, Experts Call on Licensing & Permitting Reform

The future of scalable clean energy production is also the new dawn of nuclear with the advent of small modular nuclear reactors (SMRs), a promising technology capable of revolutionizing America’s and the world’s energy landscape. As the global push for greener energy sources intensifies, these reactors present a viable pathway towards achieving significant climate…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Nick Loris · C3 SolutionsColoradoNick LorisNuclear Energy
Share

Key takeaways

01

The future of scalable clean energy production is also the new dawn of nuclear with the advent of small modular nuclear reactors (SMRs), a promising technology capable of revolutionizing America’s and the world’s energy landscape.

02

As the global push for greener energy sources intensifies, these reactors present a viable pathway towards achieving significant climate…

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

The future of scalable clean energy production is also the new dawn of nuclear with the advent of small modular nuclear reactors (SMRs), a promising technology capable of revolutionizing America’s and the world’s energy landscape. As the global push for greener energy sources intensifies, these reactors present a viable pathway towards achieving significant climate and environmental goals. As more U.S. states invest research and resources into studying the potential benefits of mass nuclear energy deployment, what does the industry need to do to speed up the adoption process?

The global decarbonization drive is fueling a resurgence in nuclear energy, with Colorado now potentially following suit thanks to the newly passed “Assess Advanced Energy Solutions In Rural Colorado” bill. Despite facing opposition over safety, cost, and environmental issues, Colorado is taking its queues from clean energy experts, who say nuclear power is necessary for true carbon-free power generation, as it can provide large-scale, low-carbon electricity continuously. Meanwhile, the U.S. Department of Energy, under the Biden administration, is promoting advanced nuclear reactor projects, though cost and technological hurdles remain. Reflecting shifting attitudes towards nuclear power, California has reversed the scheduled shutdown of the Diablo Canyon nuclear power plant in response to power shortages.

Nick Loris, Vice President of Public Policy at C3 Solutions, delves deeper into the transformative potential of small modular reactors and the critical policy reforms needed for their wider adoption in the U.S.

Nick’s Thoughts

“Small modular nuclear reactors have tremendous potential to meet America and the world’s energy needs while also meeting key environmental and climate objectives. They also have tremendous potential to meet America and the world’s energy security needs by weaning Europe off Russian natural gas. And we’ve seen American companies already committing to building SMRs in Europe. What we need is more of that action here in the United States and the collaboration between the national laboratories and the private sector is exactly what you want to see to help get a number of these technologies off the ground and to de-risk them. There’s a lot of excitement from venture capitalists to entrepreneurs and innovators, as well as the general public for nuclear power as support for the technology is the highest it’s been in 10 years.

What we really need to see now though is licensing and permitting reform. For instance, the Nuclear Regulatory Commission’s just licensed and certified NuScale’s reactor design, but it took half a billion dollars in costs for the company to get through the process, not to mention they started that process in 2008. So if we want to have more of these innovative technologies reach the marketplace to provide durable emissions-free power, we need more efficient regulatory and permitting processes while still maintaining the necessary environmental safeguards to get these technologies off the ground.”

Article written by Daniel Litwin.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

Nick Loris
Nick LorisVice President of Public Policy

You can write about your years of experience, industry, or skills. (Feel free to copy and paste your LinkedIn 'About' info here).

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

Nick Loris
Nick Loris

Vice President of Public Policy

You can write about your years of experience, industry, or skills. (Feel free to copy and paste your LinkedIn 'About' info here).

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512